Synexis BioDefense System

Name

Synexis BioDefense System

Legal name

Synexis, LLC

Website

https://synexis.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

51–100 employees

Ownership category

akta.pro rank

Product category

Indoor Air Quality and Pathogen Control Devices

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm) (HLAMAEAD)

akta.pro secondary industry

GxP Warehousing, Storage & Distribution (ambient + controlled) (HLAGAMAH)

Keywords

• Continuous pathogen control
• Indoor air quality
• Microbial reduction technology
• Dry hydrogen peroxide
• HVAC-integrated disinfection

Headquarters

HQ city

Lenexa

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Operations

Revenue model

1. Device Sales: Sale of pathogen control devices (Sphere, Sentry XL, Blade) with varying coverage capacities from 750 sq ft to 3,000 sq ft. One-time hardware purchase with ongoing consumable replacements.
2. Consumables and Maintenance: Recurring revenue from consumable replacements including catalysts (sails), UV bulbs, MERV 11 filters, and carbon filters. Scheduled replacement intervals of 6 months to 5 years depending on component. Optional Synexis support and scheduled consumable delivery available.
3. Maintenance Plans: Optional maintenance plans available with annual or recurring monthly payment options. Devices designed for light HVAC-style maintenance that most customers handle in-house.

Pricing tiers

Go-to-market motion3 records

Distribution channels11 records

Marketing channels8 records

Core offering

Synexis BioDefense System manufactures and sells hardware devices (Blade, Sentry XL, Sphere) that use its proprietary patented Dry Hydrogen Peroxide (DHP) technology to continuously reduce airborne and surface pathogens — including viruses, bacteria, fungi, mold, and VOCs — in occupied indoor environments across healthcare, food processing, animal health, poultry, education, government, and residential facilities. The company supplements hardware sales with recurring revenue from scheduled consumable replacements (catalysts/sails, UV bulbs, MERV 11 filters, carbon filters) and optional maintenance plans, selling through direct enterprise sales and a global network of channel partners and distributors.

Product overview

Synexis BioDefense System offers a portfolio of three hardware devices—Blade, Sentry XL, and Sphere—all powered by the proprietary DHP® (Dry Hydrogen Peroxide) patented technology. The Blade is an in-duct device installed into HVAC systems for whole-facility coverage, while the Sentry XL and Sphere are standalone devices serving medium and small spaces respectively. The core DHP® technology platform converts ambient oxygen and humidity into antimicrobial gas that continuously reduces pathogens in occupied spaces. The three devices form a scalable deployment system allowing coverage from small rooms (Sphere, up to 1,000 ft²) to industrial facilities (Sentry XL, up to 3,000 ft²) with the Blade providing HVAC-integrated coverage (up to 750 ft² per unit).

Differentiator

Problem solved

Functional benefit

Products and services

• Blade In-duct microbial reduction device installed directly into HVAC ductwork, enabling DHP deployment throughout an entire facility via the building's existing airflow system. Fits in-line with most HVAC systems without negatively affecting airflow, with coverage up to 750 sq ft per unit.
• Sentry XL Heavy-duty stand-alone or wall-mountable pathogen control device designed for larger indoor spaces and industrial facilities, including refrigerated spaces down to 35°F. Coverage up to 3,000 sq ft, with LED bulbs lasting 5+ years and a stainless-steel/aluminum frame.
• Sphere Compact stand-alone or wall-mountable pathogen control device for smaller rooms and targeted treatment in key zones. Plugs into a standard 120VAC/220VAC outlet with coverage up to 1,000 sq ft, with a sleek, light design for convenient deployment.
• DHP (Dry Hydrogen Peroxide) Technology Platform Proprietary patented technology platform that converts ambient oxygen and humidity into pure gas-form hydrogen peroxide (Dry Hydrogen Peroxide), creating continuous, touchless, proactive microbial-reduction pressure that deactivates airborne and surface pathogens including viruses, bacteria, fungi, and VOCs throughout indoor spaces.

Quantifiable outcome

• 99.99% in-air reduction at 90 minutes for SARS-CoV-2 (COVID-19)
• +9 more outcomes

Named customers12 records

Segments9 records

Ideal customer profiles8 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Ten partnerships are on record, tiered core, regional and strategic.

• Midwest Veterinary SupplycoreChannel Partner/ Reseller/ Distributor · 1 June 2026Strategic collaboration announced June 1, 2026 to bring Synexis DHP technology to animal health professionals nationwide. Midwest Veterinary Supply, with 65+ years of experience, enables customers to adopt and scale next-generation solutions for enhancing health and safety of indoor animal care and equine facilities. Addresses the growing need for continuous approaches to pathogen control in veterinary settings.
• Quip LabscoreChannel Partner/ Reseller/ Distributor · 20 January 2026Strategic collaboration announced January 20, 2026 to deliver comprehensive pathogen control for US life sciences research facilities. Quip Labs' 40-year history of specialized facility hygiene solutions enables research customers to efficiently procure, deploy and scale Synexis DHP technology. Complements Quip Labs' Halo Disinfection System.
• DiverseycoreChannel Partner/ Reseller/ Distributor · 24 September 2024Partnership announced September 2024 for US & Canada healthcare market. Diversey enables healthcare customers to easily and efficiently procure, deploy and scale Synexis DHP pathogen control technology. Diversey is a solutions provider designed for healthcare.
• Zamil ACregionalChannel Partner/ Reseller/ Distributor · 28 February 2024Collaboration announced February 28, 2024 for air and surface cleaning technology in Saudi Arabia and GCC region. Exclusive partnership for Middle East market expansion.
• Trane TechnologiesstrategicTechnology or Integration · 1 January 2021Collaboration formed in 2021 for US HVAC market integration. Synexis DHP technology integrates with Trane building climate control systems for enhanced indoor air quality solutions.
• IncubamasterregionalChannel Partner/ Reseller/ DistributorMexico-based poultry distributor collaboration. Partnership supports poultry biosecurity transformation in Latin American markets through local distribution and support.
• IxomregionalChannel Partner/ Reseller/ DistributorNew Zealand-based distributor for poultry and other industries in the region. Supports market expansion in Australia/New Zealand markets.
• NieserregionalChannel Partner/ Reseller/ DistributorArgentina, Uruguay, Paraguay distributor for poultry operations and biosecurity applications. Supports market expansion in South American markets.
• Royal VetregionalChannel Partner/ Reseller/ DistributorPhilippines-based distributor for animal health and poultry applications. Supports market expansion in Southeast Asian markets.
• CustomateregionalChannel Partner/ Reseller/ DistributorUnited Kingdom distributor for poultry and other industry applications. Supports market expansion in European markets.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• Molekule: Molekule uses PECO (Photo Electrochemical Oxidation) technology in standalone air purifiers, addressing consumer and light-commercial indoor air quality with a different but adjacent technology platform.
• Aura Air: Aura Air combines air quality monitoring, HEPA/UV-C filtration, and sterilization into a connected wall-mounted unit, targeting commercial and residential customers with a smart-device approach overlapping Synexis's Sphere.

Direct peers

• Global Plasma Solutions (GPS): GPS offers needlepoint bipolar ionization technology for HVAC-integrated indoor air quality improvement, competing head-to-head with Synexis DHP devices in commercial and institutional facilities.
• AtmosAir Solutions: AtmosAir provides bipolar ionization air purification systems integrated into HVAC systems for commercial buildings, directly competing with Synexis's Blade in-duct device on continuous indoor air quality.
• UV Angel: UV Angel develops UV-C light pathogen control devices for healthcare and commercial facilities, offering continuous air and surface disinfection as a competing technology platform to DHP.
• Novaerus (WellAir): Novaerus (now part of WellAir) makes plasma-based air disinfection devices for healthcare and commercial environments, directly competing with Synexis's Blade, Sphere, and Sentry XL in the continuous-pathogen-control category.
• R-Zero: R-Zero provides UV-C disinfection solutions for occupied and unoccupied indoor spaces across healthcare, education, and commercial settings, competing for the same infection-prevention budget as Synexis.

Broad incumbents

• Sharp Electronics (Plasmacluster): Sharp's Plasmacluster Ion technology is integrated into a broad portfolio of consumer and commercial air purifiers, representing a large incumbent with overlapping indoor pathogen-reduction claims and a much wider distribution footprint.
• Carrier (Carrier Global): Carrier's HVAC and indoor air quality solutions include UV and filtration integrations that compete for the same facility-improvement budgets, leveraging a global installed base and service network.
• Honeywell (Indoor Air Quality): Honeywell offers a broad portfolio of HVAC, air purification, and building-health products including UV systems, competing with Synexis at the integrated-building level rather than as a dedicated pathogen-control specialist.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/SynexisDHP
• LinkedInlinkedin.com/company/synexis
• Instagraminstagram.com/synexis_systems
• Facebookfacebook.com/SynexisBio

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Synexis BioDefense System